ROS1 and cancer: In addition, FIG-ROS1, SLC34A2-ROS1, CD74-ROS1, EZR-ROS1, TPM3-ROS1 and SDC4-ROS1 and related variants are recognized as new cancer driver genes and are associated with sensitivity to ROS1 inhibition [32-34] (Table 1).